CJC-1295 without DAC
Also known as Modified GRF 1-29
Short-acting GHRH analog
A GHRH analog with a half-life around 30 minutes, studied for amplifying natural GH pulses.
How it works
Binds pituitary GHRH receptors to increase the amplitude of an existing GH pulse, preserving the natural pulsatile rhythm rather than flattening it.
What research has shown
Pairing with a ghrelin-receptor agonist produces markedly larger GH pulses than either compound alone in published work.
Reported ranges in the literature
Low end
100 mcg per administration
Optimal
100 to 200 mcg, one to three times daily
High end
300 mcg per administration in research reports
Frequency reported in the literature: Up to three times daily in reported protocols
Protocol duration and pairing
Typical study duration
8 to 12 weeks in reported protocols.
Best paired with
Short-acting form preserves natural pulsatility, so it is paired with equally short-acting GHRPs.
Research use only
All content on this page is general reference information for laboratory research contexts. It is not medical advice, is not intended to direct human use, and does not replace guidance from a licensed healthcare professional. Not for human consumption. Must be 18+.